In a Feb. 28 rating action, Moody’s said U.S. Anesthesia Partners’ earnings could face erosion because UnitedHealth Group canceled its in-network contracts with the provider group in Texas. The contract represents about 10 percent of U.S. Anesthesia Partners’ annual revenues, and is expected to be terminated in April 2020.
“Moody’s believes that the two companies will eventually agree on modified contract terms,” the ratings action said. “However, the modified contracts could come with lower reimbursement rates for USAP, which will reduce profitability. Further, a drawn-out negotiation process may lead to disruption to hospital customers and contract losses.”
More articles on payers:
BCBS of Texas to reimburse out-of-network ER claims, pay $10M fine
BCBS of North Carolina wins $9.4B contract to manage state health plan
BCBS of North Carolina’s net income tumbles $193M on ‘record-high’ expenses
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
